KaydedilenlerDerginizi ekleyin

Dergiler / Eurasian Journal of Medical Investigation / 2021 / Cilt: 5 - Sayı: 2

The Significance of Hemogram Parameters for Diagnosis,Prognosis and Treatment of Lung Cancer

Cemil BİLİR
Ceyhun VARİM
Selcuk YAYLACI
Ayse DEMİRCİ
Ilhan HACIBEKİROĞLU
Fatma Dindar ÇELİK
Sayfa
159–165
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Results: The median survival was 13 months, survival was high in adeno carcinoma patients with17 months(median),and low in patients with carcinoid tumors and the tumors whose pathology could not be categorized with 5 months(median), (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: We aimed to investigate the relation between neutrophil/lymphocyte ratio (NLR), lymphocyte/monocyteratio (LMR) and platelet/lymphocyte ratio (PLR) with survival and mortality in lung cancer.
📊
Temel Bulgular & Veri:Methods: 309 patients diagnosed of lung cancer were evaluated in our study.
💡
Sonuç & Katkı:Results: The median survival was 13 months, survival was high in adeno carcinoma patients with17 months(median),and low in patients with carcinoid tumors and the tumors whose pathology could not be categorized with 5 months(median), (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objectives: We aimed to investigate the relation between neutrophil/lymphocyte ratio (NLR), lymphocyte/monocyteratio (LMR) and platelet/lymphocyte ratio (PLR) with survival and mortality in lung cancer. Methods: 309 patients diagnosed of lung cancer were evaluated in our study. NLR, LMR, PLR were calculated by re cording of absolute neutrophil, absolute lymphocyte, absolute monocyte and platelet values from the complete bloodcount at the time of diagnosis. The cut-off values were determined as 5.28 for NLR, 2.07 for LMR and 150 for PLR byinvestigating previous studies. Results: The median survival was 13 months, survival was high in adeno carcinoma patients with17 months(median),and low in patients with carcinoid tumors and the tumors whose pathology could not be categorized with 5 months(median), (p

🔖

Bu Makaleye Atıf Yap

BİLİR, C., VARİM, C., YAYLACI, S., DEMİRCİ, A., HACIBEKİROĞLU, I., ÇELİK, F. D. (2022). The Significance of Hemogram Parameters for Diagnosis,Prognosis and Treatment of Lung Cancer. Eurasian Journal of Medical Investigation, Cilt: 5 - Sayı: 2, 159–165. https://ajindex.com/articles/508605

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Mao Y, Yang D, He J, Krasna MJ. Epidemiology of lung cancer. Surg Oncol Clin N Am 2016;25:439–45
  2. Jacobsen MM, Silverstein SC, Quinn M, Waterston LB, Thomas CA, Benneyan JC, et al. Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review. Lung Cancer.2017;112:156–64
  3. Zhou T, Zhan J, Fang W, Zhao Y, Yang Y, Hou X, et al. Serum lowdensity lipoprotein and low-density lipoprotein expression level at diagnosis are favorable prognostic factors in patients with small-cell lung cancer (SCLC). BMC Cancer 2017;17:269
  4. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883–99
  5. Li W, Ma G, Wu Q, Deng Y, Liu Y, Wang J. Prognostic value of lymphocyte-to-monocyte ratio among Asian lung cancer patients: A systematic review and meta-analysis. Oncotarget 2017;8:110606–13
  6. Galdiero MR, Varricchi G, Loffredo S, Mantovani A, Marone G. Roles of neutrophils in cancer growth and progression. J Leukoc Biol 2018;103:457–64
  7. Zhang J, Huang SH, Li H, Li Y, Chen XL, Zhang WQ, et al. Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer. Med Oncol 2013;30:352
  8. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet (London, England) 2001;357:539–45
  9. Yuan C, Li N, Mao X, Liu Z, Ou W, Wang SY. Elevated pretreatment neutrophil/white blood cell ratio and monocyte/lymphocyte ratio predict poor survival in patients with curatively resected non-small cell lung cancer: Results from a large cohort. Thorac Cancer 2017;8:350–8
  10. Liu D, Huang Y, Li L, Song J, Zhang L, Li W. High neutrophil-tolymphocyte ratios confer poor prognoses in patients with small cell lung cancer. BMC Cancer 2017;17:882
  11. Lim JU, Yeo CD, Kang HS, Park CK, Kim JS, Kim JW, et al. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion. PLoS One 2018;13:e0200341
  12. Sakin A, Sahin S, Yasar N, Demir C, Arici S, Geredeli C, et al. The Relation between hemogram parameters and survival in extensive-stage small cell lung cancer. Oncol Res Treat 2019;42:506– 14
  13. Bunney PE, Zink AN, Holm AA, Billington CJ, Kotz CM. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol Behav 2017;176:139–48
  14. Deng M, Ma X, Liang X, Zhu C, Wang M. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymph